澳洋健康
(002172)
| 流通市值：24.95亿 | | | 总市值：24.96亿 |
| 流通股本：7.65亿 | | | 总股本：7.66亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,501,392,158.94 | 1,031,673,386.92 | 581,691,001.68 | 2,173,767,566.03 |
| 营业收入 | 1,501,392,158.94 | 1,031,673,386.92 | 581,691,001.68 | 2,173,767,566.03 |
| 二、营业总成本 | 1,443,960,814.85 | 985,610,124.05 | 541,279,571.75 | 2,118,225,391.37 |
| 营业成本 | 1,295,449,367.85 | 892,554,002.46 | 501,631,418.01 | 1,880,631,380.05 |
| 税金及附加 | 8,073,208.03 | 5,173,051.25 | 2,552,656.57 | 11,011,829.35 |
| 销售费用 | 32,167,433.29 | 21,540,246.14 | 10,239,875.05 | 49,239,183.85 |
| 管理费用 | 92,868,985.94 | 60,413,296.48 | 30,094,776.78 | 144,443,830.79 |
| 研发费用 | 0 | 0 | - | - |
| 财务费用 | 15,401,819.74 | 5,929,527.72 | -3,239,154.66 | 32,899,167.33 |
| 其中:利息费用 | 32,794,633.63 | 20,903,912.87 | 12,844,516.94 | 43,185,135.58 |
| 其中:利息收入 | 22,325,884.44 | 19,767,766.31 | 18,925,321.04 | 24,424,521.67 |
| 加:投资收益 | -460,456.68 | -386,950.6 | -386,950.6 | 20,766,204.27 |
| 资产处置收益 | -5,898.86 | -6,595.6 | -51.66 | 29,446.76 |
| 信用减值损失(新) | 4,848,236.73 | 5,470,251.98 | -4,465,533.43 | 556,838.35 |
| 其他收益 | 1,478,419.13 | 767,329.1 | 396,939.05 | 5,091,542.11 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 63,291,644.41 | 51,907,297.75 | 35,955,833.29 | 81,986,206.15 |
| 加:营业外收入 | 4,700,827.78 | 4,314,318.74 | 4,274,558.44 | 13,436,219.86 |
| 减:营业外支出 | 3,161,868.6 | 1,787,841.14 | 1,419,476.54 | 25,477,949.72 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 64,830,603.59 | 54,433,775.35 | 38,810,915.19 | 69,944,476.29 |
| 减:所得税费用 | 25,207,774.87 | 16,381,096.02 | 7,673,089.57 | 19,681,089.89 |
| 六、净利润 | 39,622,828.72 | 38,052,679.33 | 31,137,825.62 | 50,263,386.4 |
| 持续经营净利润 | 39,622,828.72 | 38,052,679.33 | 31,137,825.62 | 50,263,386.4 |
| 归属于母公司股东的净利润 | 38,678,072.35 | 37,327,960.74 | 30,739,368.29 | 49,681,623.57 |
| 少数股东损益 | 944,756.37 | 724,718.59 | 398,457.33 | 581,762.83 |
| (一)基本每股收益 | 0.05 | 0.05 | 0.04 | 0.06 |
| (二)稀释每股收益 | 0.05 | 0.05 | 0.04 | 0.06 |
| 九、综合收益总额 | 39,622,828.72 | 38,052,679.33 | 31,137,825.62 | 50,263,386.4 |
| 归属于母公司股东的综合收益总额 | 38,678,072.35 | 37,327,960.74 | 30,739,368.29 | 49,681,623.57 |
| 归属于少数股东的综合收益总额 | 944,756.37 | 724,718.59 | 398,457.33 | 581,762.83 |
| 公告日期 | 2024-10-31 | 2024-08-29 | 2024-04-30 | 2024-04-27 |
| 审计意见(境内) | | | | 标准无保留意见 |